JP2020519645A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020519645A5 JP2020519645A5 JP2019562579A JP2019562579A JP2020519645A5 JP 2020519645 A5 JP2020519645 A5 JP 2020519645A5 JP 2019562579 A JP2019562579 A JP 2019562579A JP 2019562579 A JP2019562579 A JP 2019562579A JP 2020519645 A5 JP2020519645 A5 JP 2020519645A5
- Authority
- JP
- Japan
- Prior art keywords
- hadsc
- pellet
- tissue
- adipose tissue
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762506006P | 2017-05-15 | 2017-05-15 | |
| US62/506,006 | 2017-05-15 | ||
| PCT/IL2018/050523 WO2018211498A1 (en) | 2017-05-15 | 2018-05-14 | Treatment of multiple sclerosis with adipose-derived stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020519645A JP2020519645A (ja) | 2020-07-02 |
| JP2020519645A5 true JP2020519645A5 (enExample) | 2021-05-06 |
Family
ID=64274150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019562579A Pending JP2020519645A (ja) | 2017-05-15 | 2018-05-14 | 脂肪組織由来幹細胞による多発性硬化症の治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11510946B2 (enExample) |
| EP (1) | EP3624816A4 (enExample) |
| JP (1) | JP2020519645A (enExample) |
| CN (1) | CN110573170A (enExample) |
| AU (1) | AU2018270396B2 (enExample) |
| CA (1) | CA3062123A1 (enExample) |
| IL (1) | IL269893B2 (enExample) |
| WO (1) | WO2018211498A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL269893B2 (en) | 2017-05-15 | 2023-10-01 | Stem Cell Medicine Ltd | Treatment of multiple sclerosis with adipose-derived stem cells |
| CA3062964C (en) | 2017-05-15 | 2024-11-12 | Mapi Pharma Ltd. | TREATMENT OF MULTIPLE SCLEROSIS WITH A LONG-ACTING GLATIRAMER AND ADIPE-DERIVED STEM CELLS |
| IL272145A (en) | 2020-01-20 | 2021-07-29 | Stem Cell Medicine Ltd | Cosmetic compositions with protein concentrate from conditioned medium of adipose-derived stem cells |
| CN115624571A (zh) * | 2022-12-21 | 2023-01-20 | 北京瑷格干细胞科技有限公司 | 人脂肪间充质干细胞在制备治疗硬皮病药物中的应用 |
| CN115624570A (zh) * | 2022-12-21 | 2023-01-20 | 北京瑷格干细胞科技有限公司 | 人脂肪间充质干细胞在制备治疗结缔组织疾病药物中的应用 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL36670A (en) | 1971-04-21 | 1974-09-10 | Sela M | Therapeutic basic copolymers of amino acids |
| US5800808A (en) | 1994-05-24 | 1998-09-01 | Veda Research And Development Co., Ltd. | Copolymer-1 improvements in compositions of copolymers |
| US6214791B1 (en) | 1997-01-10 | 2001-04-10 | Yeda Research And Development Co. Ltd. | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| ATE302020T1 (de) | 2000-01-20 | 2005-09-15 | Yeda Res & Dev | Verwendung von copolymer 1- und verwandten peptiden sowie von polypeptiden und damit behandelten t-zellen zur neuroprotektiven therapie |
| US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
| ZA200505733B (en) | 2003-01-21 | 2006-10-25 | Yeda Res & Dev | COP 1 for treatment of inflammatory bowel diseases |
| US7429378B2 (en) | 2003-05-13 | 2008-09-30 | Depuy Spine, Inc. | Transdiscal administration of high affinity anti-MMP inhibitors |
| ES2541780T3 (es) | 2004-11-29 | 2015-07-24 | Yeda Research And Development Co., Ltd. | Inducción de la neurogénesis y terapia con células madre en combinación con el Copolímero 1 |
| WO2006060779A2 (en) | 2004-12-03 | 2006-06-08 | Case Western Reserve University | Novel methods, compositions and devices for inducing neovascularization |
| JP4654015B2 (ja) | 2004-12-08 | 2011-03-16 | 京セラ株式会社 | カメラ装置 |
| US20070003528A1 (en) | 2005-06-29 | 2007-01-04 | Paul Consigny | Intracoronary device and method of use thereof |
| AU2006304277B2 (en) | 2005-10-13 | 2012-07-05 | Celularity Inc. | Immunomodulation using placental stem cells |
| EP1795588A1 (en) | 2005-12-07 | 2007-06-13 | Cellerix, S.L. | Use of adipose tissue derived mesenchymal stem cells for the treatment of graft versus host disease |
| US8021882B2 (en) | 2006-08-24 | 2011-09-20 | Johnstone Brian H | Production of neural protective and regenerative factors from stem cells and treatment of nervous system conditions therewith |
| LT2086332T (lt) | 2006-11-03 | 2018-04-25 | Multiple Sclerosis Research Center Of New York | Mezenchiminės kamieninės ląstelės, gautos iš kaulų čiulpų, kaip neuroninių pradininkų šaltinis |
| WO2011041240A1 (en) | 2009-09-30 | 2011-04-07 | The Brigham And Women's Hospital, Inc. | Tissue transplant compositions and methods for use |
| US8703180B1 (en) | 2007-10-23 | 2014-04-22 | Abbott Cardiovascular Systems Inc. | Multiple growth factor compositions, methods of fabrication, and methods of treatment |
| EP2278873B1 (en) * | 2008-03-19 | 2015-05-06 | Cryo-Save AG | Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells |
| US20090291061A1 (en) | 2008-05-21 | 2009-11-26 | Riordan Neil H | Stem cell therapy for blood vessel degeneration |
| US8663987B2 (en) | 2008-05-28 | 2014-03-04 | Ramot At Tel-Aviv University Ltd. | Mesenchymal stem cells for the treatment of CNS diseases |
| US20110129450A1 (en) | 2008-08-01 | 2011-06-02 | Orly Lazarov | Method of promoting neurogenesis by modulating secretase activities |
| US8404866B2 (en) | 2008-09-03 | 2013-03-26 | Florida State University Research Foundation | Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors |
| US20110274667A1 (en) | 2008-10-17 | 2011-11-10 | Baxter Healthcare S.A. | Methods for obtaining cell populations from adipose tissue |
| JP5515319B2 (ja) | 2009-02-23 | 2014-06-11 | 富士レビオ株式会社 | 脂肪細胞への分化誘導培地及び方法 |
| EP3150703A1 (en) | 2009-07-09 | 2017-04-05 | TiGenix, S.A.U. | Cells for use in a method for treating inflammatory and/or immune disorders |
| DK3536333T3 (da) | 2010-01-04 | 2022-10-24 | Mapi Pharma Ltd | Depotsystem der omfatter glatirameracetat |
| US8377885B2 (en) | 2010-01-04 | 2013-02-19 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| US20110212065A1 (en) | 2010-02-18 | 2011-09-01 | Timothy Jansen | Methods of manufacture of therapeutic products comprising vitalized placental dispersions |
| EP2699317B1 (en) | 2011-04-21 | 2016-08-10 | Mapi Pharma Limited | Random pentapolymer for treatment of autoimmune diseases |
| US20130034524A1 (en) | 2011-08-03 | 2013-02-07 | Siamak Agha-Mohammadi | Non-Enzymatic Method for Harvesting Adipose-Derived Stromal Cells and Adipose-Derived Stem Cells from Fat and Lipo-Aspirate |
| DK2744892T3 (en) | 2011-09-23 | 2019-04-23 | Cell Ideas Pty Ltd | THERAPEUTICS USING FAT CELLS AND CELL SECRETIONS |
| CL2011002642A1 (es) | 2011-10-24 | 2012-04-09 | Univ Del Desarrollo | Uso de una composicion formada por un glucocorticoide y una tiazolinediona que sirve para inducir la diferenciacion adipogenica en celulas madres. |
| EP2623110A1 (en) | 2012-01-31 | 2013-08-07 | CSL Behring GmbH | Factor XII inhibitors for the treatment of neurological inflammatory disorders |
| WO2013137826A1 (en) | 2012-03-12 | 2013-09-19 | National University Of Singapore | Generation of brown adipose tissue (bat) from mesenchymal cells |
| CN104130975B (zh) * | 2013-05-03 | 2018-07-17 | 上海市东方医院 | 人源脂肪干细胞来源的神经元样细胞及其制备方法和应用 |
| TWI642781B (zh) | 2014-02-06 | 2018-12-01 | 仲恩生醫科技股份有限公司 | 具優異細胞保護及免疫調節之ｑｕａｄｒｉ－正之基質細胞 |
| WO2015120388A1 (en) * | 2014-02-10 | 2015-08-13 | Cytori Therapeutics, Inc. | Regenerative cell therapy for central nervous system (cns) disorders and ptsd |
| KR20190084207A (ko) | 2016-02-12 | 2019-07-16 | 셀 케어 테라퓨틱스, 인크. | 지방 조직 유래의 중간엽 기질 세포 조정 배지 및 이것의 제조 및 사용 방법 |
| US12161688B2 (en) | 2016-06-30 | 2024-12-10 | Mapi Pharma Ltd | Treatment of inflammatory bowel disease with long acting glatiramer and adipose-derived stem cells |
| IL269893B2 (en) | 2017-05-15 | 2023-10-01 | Stem Cell Medicine Ltd | Treatment of multiple sclerosis with adipose-derived stem cells |
-
2018
- 2018-05-14 IL IL269893A patent/IL269893B2/en unknown
- 2018-05-14 US US16/613,369 patent/US11510946B2/en active Active
- 2018-05-14 CA CA3062123A patent/CA3062123A1/en active Pending
- 2018-05-14 EP EP18801976.4A patent/EP3624816A4/en not_active Ceased
- 2018-05-14 JP JP2019562579A patent/JP2020519645A/ja active Pending
- 2018-05-14 AU AU2018270396A patent/AU2018270396B2/en active Active
- 2018-05-14 CN CN201880028213.1A patent/CN110573170A/zh active Pending
- 2018-05-14 WO PCT/IL2018/050523 patent/WO2018211498A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020519645A5 (enExample) | ||
| Sun et al. | Single-cell RNA-seq highlights heterogeneity in human primary Wharton’s jelly mesenchymal stem/stromal cells cultured in vitro | |
| Parekkadan et al. | Mesenchymal stem cells as therapeutics | |
| Nagamura-Inoue et al. | Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility | |
| Mildmay-White et al. | Cell surface markers on adipose-derived stem cells: a systematic review | |
| Trohatou et al. | Mesenchymal stem/stromal cells in regenerative medicine: past, present, and future | |
| Sivasubramaniyan et al. | Phenotypic and functional heterogeneity of human bone marrow–and amnion‐derived MSC subsets | |
| Keating | Mesenchymal stromal cells: new directions | |
| Lavoie et al. | Uncovering the secretes of mesenchymal stem cells | |
| Zhang et al. | Isolation and characterization of mesenchymal stem cells from whole human umbilical cord applying a single enzyme approach | |
| Otsuru et al. | Improved isolation and expansion of bone marrow mesenchymal stromal cells using a novel marrow filter device | |
| Baer et al. | Adipose‐derived mesenchymal stromal/stem cells: tissue localization, characterization, and heterogeneity | |
| Tong et al. | Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method | |
| EP2975118B1 (en) | Generation of a mesenchymal stromal cell bank from the pooled mononuclear cells of multiple bone marrow donors | |
| Goligorsky | Endothelial progenitor cells: from senescence to rejuvenation | |
| Bogdanova et al. | Characterization of human adipose-derived stem cells cultured in autologous serum after subsequent passaging and long term cryopreservation | |
| Fazzina et al. | A new standardized clinical‐grade protocol for banking human umbilical cord tissue cells | |
| Song et al. | Variations of clonal marrow stem cell lines established from human bone marrow in surface epitopes, differentiation potential, gene expression, and cytokine secretion | |
| Zhou et al. | Amniotic fluid-derived mesenchymal stem cells: characteristics and therapeutic applications | |
| US20240115618A1 (en) | Treatment of diseases of endothelial dysfunction and inflammation | |
| CN103421739B (zh) | 一种高效分离脐带间充质干细胞的方法 | |
| Hosseini et al. | Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome | |
| Chen et al. | The biological characteristics of sheep umbilical cord mesenchymal stem cells | |
| CN105025927B (zh) | 人cd34阴性祖细胞保护血管内皮细胞层避免免疫介导的细胞毒性反应 | |
| Jin et al. | Stem cell‐based cell therapy for glomerulonephritis |